Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Sophia Genetics Q2 EPS $(0.33) Misses $(0.23) Estimate, Sales $18.323M Beat $17.480M Estimate

Author: Benzinga Newsdesk | August 05, 2025 05:46am
Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.33) per share which missed the analyst consensus estimate of $(0.23) by 43.48 percent. This is a 43.48 percent decrease over losses of $(0.23) per share from the same period last year. The company reported quarterly sales of $18.323 million which beat the analyst consensus estimate of $17.480 million by 4.82 percent. This is a 15.91 percent increase over sales of $15.808 million the same period last year.

Posted In: SOPH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist